Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 1, 2012
Patent Application Number
10518016
Date Filed
June 13, 2003
Patent Citations Received
Patent Primary Examiner
Patent abstract
A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
